Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acer Therapeutics
Acer Therapeutics
(ACER)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Olpruva
Phenylbutyric acid
2022-12-22
Ornithine carbamoyltransferase deficiency disease
,
Carbamoyl-phosphate synthase i deficiency disease
,
Citrullinemia
,
Amyotrophic lateral sclerosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Phenylbutyric acid
alzheimer disease
,
central nervous system diseases
,
nervous system diseases
,
spinal cord diseases
,
tdp-43 proteinopathies
,
neuromuscular diseases
,
syndrome
,
wolfram syndrome
,
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
neurodegenerative diseases
,
parkinsonian disorders
,
progressive supranuclear palsy
,
paralysis
Celiprolol
ehlers-danlos syndrome
,
type iv ehlers-danlos syndrome
Bevifimod
neoplasms
,
carcinoma
,
non-small-cell lung carcinoma
,
renal insufficiency
,
urologic neoplasms
,
liver failure
,
breast neoplasms
,
ovarian neoplasms
,
endometrial neoplasms
,
head and neck neoplasms
,
lung neoplasms
,
melanoma
,
transitional cell carcinoma
,
unknown primary neoplasms
,
neoplasm metastasis
,
testicular neoplasms
,
ovarian epithelial carcinoma
,
type 2 diabetes mellitus
,
sarcoidosis
,
hidradenitis suppurativa
,
abscess
,
fistula
,
asthma
,
non-hodgkin lymphoma
,
multiple myeloma
,
lymphoma
,
hodgkin disease
,
mantle-cell lymphoma
,
skin diseases
,
arthritis
,
ankylosing spondylitis
,
prostatic neoplasms
,
ulcerative colitis
,
juvenile arthritis
,
infections
,
psoriatic arthritis
,
chronic renal insufficiency
,
kidney diseases
,
inflammation
,
protein-energy malnutrition
,
congenital heart defects
,
premature birth
,
bronchopulmonary dysplasia
,
respiratory syncytial virus infections
,
inflammatory bowel diseases
,
precocious puberty
,
exocrine pancreatic insufficiency
,
mucositis
,
giant cell arteritis
,
spondylarthritis
,
hypoalbuminemia
,
oxidative stress
,
interstitial cystitis
,
rheumatoid arthritis
,
psoriasis
,
crohn disease
,
malnutrition
,
diabetes mellitus
,
esophageal neoplasms
,
hip fractures
,
coronary artery disease
,
cardiovascular diseases
,
bone fractures
,
hiv infections
,
acquired immunodeficiency syndrome
,
covid-19
,
human influenza
,
pressure ulcer
,
malaria
,
pain
,
fatigue
,
stomach neoplasms
,
gastrointestinal stromal tumors
,
chronic pain
,
failed back surgery syndrome
,
sciatica
,
critical illness
,
enteral nutrition
,
bradycardia
,
hepatocellular carcinoma
,
liver neoplasms
,
influenza b virus
Zotiraciclib
multiple sclerosis
,
disease progression
,
neoplasm metastasis
,
autoimmune diseases
,
nervous system diseases
,
autoimmune diseases of the nervous system
,
chronic progressive multiple sclerosis
,
sclerosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use